Literature DB >> 590649

The monocyte as a model for the study of insulin receptors in man.

H Beck-Nielsen, O Pedersen, K Kragballe, N S Sorensen.   

Abstract

We have characterized the cellular composition of preparations isolated from peripheral blood by Ficoll-Isopaque gradient centrifugation. 125I-insulin binding to every cell type was measured. A highly significantly positive correlation between specific cell binding fraction and the monocyte concentration of the heterogeneous cell suspension was demonstrated. Depletion of monocytes reduced the insulin binding approximately 80%, which confirms previous findings by other investigators. The granulocytes possessed the second highest binding ability, but only one fourteenth of that of monocytes. Compared to the lymphocyte the monocyte had about 25 times greater insulin binding. Also thrombocytes bound insulin and contamination with these meant that their contribution to the total specific cell binding was not negligible. A reduction in these contaminants is essential. We found that insulin binding to erythrocytes was insignificant. A method of calculating the specific insulin binding to monocytes alone is introduced. The monocyte-insulin-receptor possesses specificity. Only an insignificant degradation of receptor bound insulin could be shown. Evidence of negative cooperativity between receptors was found. Consequently monocytes are considered a useful model for insulin receptor studies in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590649     DOI: 10.1007/bf01236308

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  A new method for preparing buffy coat-poor blood.

Authors:  T J GREENWALT; M GAJEWSKI; J L McKENNA
Journal:  Transfusion       Date:  1962 Jul-Aug       Impact factor: 3.157

2.  Binding and degradation of 125I-insulin by rat hepatocytes.

Authors:  S Terris; D F Steiner
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

3.  Cooperativity in ligand binding: a new graphic analysis.

Authors:  P De Meyts; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

4.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

5.  Characteristics of the human lymphocyte insulin receptor.

Authors:  J R Gavin; P Gorden; J Roth; J A Archer; D N Buell
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

6.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

7.  A rapid technique for separation of thymocytes from suspensions by centrifugation through silicone oil.

Authors:  P A Andreasen; B P Schaumburg; K Osterline; J Vinten; S Gammeltoft; J Gliemann
Journal:  Anal Biochem       Date:  1974-06       Impact factor: 3.365

8.  Emergence of insulin receptors on human lymphocytes during in vitro transformation.

Authors:  U Krug; F Krug; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

9.  Insulin receptors in human circulating cells and fibroblasts.

Authors:  J R Gavin; J Roth; P Jen; P Freychet
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

10.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  23 in total

1.  Insulin induces tyrosine dephosphorylation of a 92 kDA protein in suspended monocytes.

Authors:  G Zoppini; P Galante; M Zardini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 2.  Insulin receptors and the clinician.

Authors:  R Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-05

3.  Characterization of differences in insulin receptors from young and old red blood cells.

Authors:  A Camagna; L Rossetti; R De Pirro; M Di Franco; R Lauro; P Samoggia; P Caprari; G Salvo
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

4.  Effects of diet on the cellular insulin binding and the insulin sensitivity in young healthy subjects.

Authors:  H Beck-Nielsen; O Pedersen; N S Sørensen
Journal:  Diabetologia       Date:  1978-10       Impact factor: 10.122

5.  Evidence for the presence of insulin binding sites in isolated rat intestinal epithelial cells.

Authors:  M E Forgue-Lafitte; M R Marescot; M C Chamblier; G Rosselin
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

6.  Primary hyperparathyroidism is associated with decreased insulin receptor binding and glucose intolerance.

Authors:  R Prager; G Schernthaner; J Kovarik; G Cichini; K Klaushofer; R Willvonseder
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

7.  Response of insulin receptors to oral glucose in normal subjects.

Authors:  A Bertoli; R De Pirro; A V Greco; A Fusco; L Spallone; G Ghirlanda; R Lauro
Journal:  J Endocrinol Invest       Date:  1980 Jan-Mar       Impact factor: 4.256

8.  Platelet insulin receptor determination in non-insulin dependent diabetes mellitus.

Authors:  M Udvardy; G Pfliegler; K Rak
Journal:  Experientia       Date:  1985-03-15

9.  Insulin receptors on monocytes of young healthy persons correlated with glucose tolerance and insulin sensitivity.

Authors:  H Beck-Nielsen; O Pedersen
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

10.  Demonstration and partial characterization of insulin receptors in human platelets.

Authors:  A S Hajek; J H Joist; R K Baker; L Jarett; W H Daughaday
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.